Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

NCT04120311 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
2
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Targeted Therapy Technologies, LLC